MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Management Presents During Chardan Transport Platform Tech Series

 Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine learning, offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping, participated in Chardan’s recent Transport Platform Tech Series event. The event brought together key industry players and highlighted the company’s focus on revolutionizing cross-border shipping through its advanced technology platform: Fr8App. During the conference, Freight Technologies CEO Javier Selgas and CFO Don Quinby spoke, presenting the company’s vision for transforming the traditional, complicated process of over-the-road (“OTR”) shipping into a more efficient, transparent and flexible operation. The duo also discussed challenges the shipping industry faces as well as current trends. “What we are doing here is creating a huge network of carriers that are able to move cross-border loads from Mexico to the U.S. and Canada and back,” said Freight Technologies CEO Javier Selgas in the press release. “Our platform makes the process of delivering goods more efficient by bringing intuitive technology to handle operations in a more streamlined way. Furthermore, we have a talented and dedicated team of operations professionals who are always available to assist shippers and carriers in navigating , transacting and managing shipments across the Fr8App platform.”

To view the full press release, visit https://ibn.fm/DsdZz

About Freight Technologies Inc. 

Freight Technologies is a technology company developing solutions to optimize and automate the supply chain process. Its wholly owned subsidiary, Freight App Inc. (“Fr8App”), is a business-to-business, cross-border shipping marketplace in the United States-Mexico-Canada Agreement (“USMCA”) region powered by artificial intelligence (“AI”) and machine learning. Focused on making shipping transparent and efficient, Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road (“OTR”) shipping. Fr8App uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via innovative technologies such as live pricing and real-time tracking, digital freight marketplace, transportation management, fleet management and committed capacity solutions. The company is headquartered in Houston, Texas. For more information about the company, please visit www.FR8Technologies.com.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO; Set for First Tirzepatide Molecule Study

 

• Lexaria, a global innovator in drug delivery platforms, recently announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study
• The study, a randomized, crossover investigation, will evaluate a dual-action glucagon-like peptide 1 (“GLP-1”) + glucose-dependent insulintropic peptide (“GIP”)
• It will measure absorption, tolerability, pharmacokinetics, and blood sugar levels
• Lexaria is counting on its patented DehydraTECH technology for significant growth in the 2024 calendar year, and the study reflects this commitment

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study. This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. The manufacturing of test articles for the study is expected to be completed soon, and the approval of an Independent Review Board (“IRB”) will be required before the study commences (https://ibn.fm/OrA8d).

This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (“GIP”), specifically measuring absorption, tolerability, pharmacokinetics, and blood sugar levels. It will compare injected tirzepatide (Zepbound(R) by Eli Lilly) to a compound formulated, tirzepatide derived from Zepbound(R) and processed by Lexaria’s patented DehydraTECH technology. The objective would be to evaluate whether DehydraTECH-processed tirzepatide, when taken orally, offers any absorption into the human bloodstream and, if so, how much.

This will mark Lexaria’s first-ever work with the tirzepatide molecule while also presenting an opportunity for alternative drug delivery, particularly given that tirzepatide is currently only available in injected form.

“Many GLP-1 drugs have produced unpleasant side effects, especially when dosed through oral tablets,” noted Chris Bunka, Lexaria’s CEO. “Lexaria’s latest study in an oral capsule hopes to evidence improved tolerability while also producing measurable quantities of drug in blood. This will be Lexaria’s first-ever work with the tirzepatide molecule and, as such, any noteworthy delivery of tirzepatide through oral delivery could be a significant finding,” he added.

Lexaria is counting on its DehydraTECH technology for significant growth in the 2024 calendar year. This study reflects this commitment and affirms the leadership’s confidence in the technology. It further looks to build on the technology’s success, as demonstrated in various studies since 2016, having shown its ability to increase bio-absorption compared to standard industry formulations. Lexaria’s management is optimistic that 2024 will be the company’s best year yet, and its tirzepatide study will be a testament to that.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

SuperCom Ltd. (NASDAQ: SPCB) Wins New Contract to Provide Rehabilitative Services to Juveniles

 

• Israel-based SuperCom Ltd. provides a range of digital monitoring solutions to government agencies in need of technology capabilities for security purposes
• SuperCom’s PureSecurity Suite of products is particularly popular and purposeful in helping court programs to monitor suspects and offenders in rehabilitation programs as the individuals are granted supervised release from custody instead of being kept behind bars
• SuperCom recently announced it had secured a new contract with a Northern California client that further demonstrates its competitiveness and its ability to provide rehabilitative services and secure solutions
• The contract works with youth offenders in a rehabilitation program and is designed to help reduce recidivism

Secure identification and digital monitoring solutions company SuperCom (NASDAQ: SPCB) recently secured a new contract for monitoring youths transitioning through California’s justice system, demonstrating SuperCom’s competitiveness and ability to build on its reputation with existing clients.

The case management services will be provided for the California client through SuperCom’s fully owned subsidiary, Leaders in Community Alternatives (“LCA”), which provides evidence-based, community-focused services and electronic monitoring programs as a private contractor to government agencies.

“This new contract allows us to expand our reach and offer our services to a new community,” SuperCom President and CEO Ordan Trabelsi stated (https://ibn.fm/RrWeV). “With this new project, SuperCom continues to strengthen its position as a leader in providing rehabilitative services and secure solutions.”

The California contract reflects a trend worldwide for court and law enforcement advocates to seek privately contracted rehabilitative service and electronic monitoring (“EM”) solutions providers that allow teen suspects to enjoy a measure of freedom and community interaction while under court supervision, with the hope of reducing recidivism.

SuperCom’s technology (https://ibn.fm/LoAHT) has the capacity to placate critics of such measures who fear EM programs will stigmatize children and “expand the walls of youth prisons into children’s homes and communities.”

The company’s monitors are easily concealable to reduce concerns about stigmatizing their wearers while providing effective, cost-efficient monitoring with artificial intelligence (“AI”) enhanced data analysis and predictive modeling that meets law enforcement needs for protecting the community.

The new contract also builds on SuperCom’s global reach that thus far includes clients mainly in Europe and the United States.

“This program underscores our commitment to providing comprehensive support services that make a tangible difference in the lives of young individuals. By focusing on evidence-based case management, we are addressing some of the most pressing needs of youth in transition,” Organ added.

Market analysts predict the court-administered EM sector may reach $2.3 billion in global revenues by 2029 at a 9.5 percent CAGR (https://ibn.fm/nMcHq), reflecting the opportunities available to SuperCom and its PureSecurity Suite of products.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Emphasizes the Importance of Mining Industry During Speech at NYC SME’s Annual Current Trends in Mining Finance Conference

 

• Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, emphasizing the importance of mining in sustaining modern civilization
• McEwen pointed out that those opposed to mining often cite environmental concerns, but they fail to recognize the unintended consequences of shutting down industries that are fundamental to modern living
• McEwen offered 10 strategic recommendations to make mining relevant to the public and address industry challenges

Rob McEwen, CEO of McEwen Mining (NYSE: MUX) (TSX: MUX), an asset rich diversified gold and silver producer in the Americas, recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving its public perception. His address highlighted the stark reality of a world without mining and its interconnected industries, particularly oil and gas.

McEwen began by challenging the audience to imagine a world devoid of mining, pointing out that while such a scenario might seem amusing momentarily, it would quickly lead to the collapse of modern civilization. The necessity of mining for the continuation of contemporary life is undeniable, yet, as McEwen pointed out, a significant portion of the population remains blissfully unaware of this fact. This ignorance is compounded by societal conditioning that teaches a deep-seated hatred for the industry.

The opposition to mining, often rooted in environmental concerns, fails to recognize the unintended consequences of shutting down an industry fundamental to modern life. McEwen also stressed that removing hydrocarbons from our lives would lead to a dystopian future, a collapse far more chaotic and desperate than most could imagine.

The central theme of McEwen’s speech was the urgent need to alter the public’s negative perception of the mining industry. This change, he argued, could be achieved by showcasing the industry’s essential contributions to daily life and modern technologies, particularly those aimed at combating climate change. By highlighting the vast range of products derived from minerals and the environmental stewardship efforts within the industry, McEwen believes the public can be swayed to view mining more favorably.

McEwen acknowledged the effectiveness of the opposition’s campaign, particularly among the youth, who are taught from a young age to view mining as destructive. To counteract this narrative, he proposed a proactive approach: educating educators, utilizing modern media tools, and presenting vivid, positive examples of the industry’s impact on local communities and the environment.

To make mining relevant to the public and address the industry’s challenges, McEwen offered ten strategic recommendations:

• Surprise the Majority: Educate the public about their everyday reliance on mining, especially in technologies that combat climate change.
• Broaden Our Reach & Turn up the Volume: Engage suppliers and allied industries in promoting the benefits of mining.
• Showcase Environmental Protection: Highlight reclamation successes and ongoing environmental protection efforts.
• Share Community Stories: Emphasize the positive impact of mining on local businesses, services, and job opportunities.
• Educate Influencers: Show the critical connection between mining, modern life, and climate change mitigation, while promoting career opportunities.
• Improve Remote Site Conditions: Enhance accommodations and benefits to attract top talent.
• Highlight Compensation & Career Paths: Showcase the high pay and rapid career advancement opportunities in mining.
• Join Forces with Oil & Gas: Collaborate on marketing efforts to improve public perception.
• Pressure Governments: Lobby for political support and recognition of mining’s contribution to modern life.
• Address Workforce Shrinkage: Embrace automation and AI to mitigate the shrinking workforce.

McEwen drew inspiration from successful industry transformations, such as Uber’s disruption of the taxi industry and Tesla’s revolution in electric vehicles. These examples demonstrate the power of addressing public complaints and delivering a superior customer experience. By adopting a similar approach, the mining industry can reshape its image and gain broader acceptance.

Working together to change opinions and highlight the industry’s essential contributions, McEwen believes the mining sector can prevent a world that is “naked, homeless, and hungry.” It is time for the industry to step onto the global stage with a message of relevance, responsibility, and opportunity, he explained.

For more information, visit the company’s website at www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

 Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation that compares three 7 mg semaglutide dose formulations, the study evaluates three doses: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsule; and for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. The study is designed to measure tolerability and side effects as well as semaglutide and blood glucose levels. Rybelsus (semaglutide) is the only GLP-1 drug approved by the FDA for oral dosingto treat diabetes and weight loss. “Blood samples will be taken multiple times during the first 10 hours post dosing,” the company stated in the press release. “A final blood draw will be taken 24 hours after dosing, and a standardized meal will be fed to the test subjects at a point in time after dosing. Nine healthy subjects are expected to be dosed with each test article with roughly a 30-day ‘washout’ interval between each dosing visit.

To view the full press release, visit https://ibn.fm/sauVZ

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery formulation and processing platform technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 43 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference

 Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has announced that management will present at the Emerging Growth Conference. Clene’s presentation is slated to begin at 2:20 p.m. on June 12, 2024, and include a corporate presentation with questions and-answers. Interested parties can visit https://ibn.fm/A217J to register for and view the webcast, which will also be available on the Events section of the Clene website. A replay of the presentation will be available as detailed in the announcement.

To view the full press release, visit https://ibn.fm/IOjYQ

About Clene Inc.

Clene (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and multiple sclerosis. CNM-Au8(R) is an investigational first-in-class therapy that improves central nervous system cells’ survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8(R) is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Astrotech Corp. (NASDAQ: ASTC) Subsidiary, “1st Detect”, Focuses on Superior Narcotics Trace Detection For Airport and Other Security Sites

 

• Astrotech Corporation Subsidiary 1st Detect Approved as GSA Vendor; Introduces Advanced Narcotics Trace Detection Technology
• 1st Detect has now received approval from the U.S. General Services Administration (“GSA”) as an authorized vendor for government-related applications
• 1st Detect recently introduced a state-of-the-art Narcotics Trace Detection (“NTD”) narcotics library, which is particularly useful for detection at points of entry and government agencies involved in combating the illicit drug trade
• 1st Detect’s portfolio now includes the TRACER 1000, Explosives Trace Detection (“ETD”) and Narcotics Trace detection

Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. With recent approval as a U.S. General Services Administration (“GSA”) authorized vendor, 1st Detect is poised to expand its impact across government agencies. TRACER 1000, a cutting-edge detector utilizing ruggedized mass spectrometry technology for superior detection at critical security points. 1st Detect’s commitment to excellence is underscored by its recent achievements and milestones, including its approval by the U.S. General Services Administration as an authorized vendor for key government-related applications (https://ibn.fm/EdwZq). This opens doors to 1st Detect’s products to a wide array of opportunities within government agencies tasked with ensuring national security.

At the heart of 1st Detect’s portfolio lies the TRACER 1000, a cutting-edge trace detector leveraging ruggedized mass spectrometry technology. This instrument represents the pinnacle of innovation in both ETD and now NTD, offering unmatched performance and versatility for security screening applications (https://ibn.fm/S1M7x).

Key features of the TRACER 1000:

• Ruggedized mass spectrometry technology
• Simple to use interface
• Seamless integration of new narcotics libraries

This development is particularly crucial for airport security and government agencies involved in combating the illicit drug trade by making updates for new drug profiles easy. By incorporating such advancements in mass spectrometry technology widely regarded as the “gold standard” in the industry, Astrotech has set a new standard for accuracy and reliability in narcotics detection.

Astrotech’s commitment to innovation and excellence was on full display at the recent ISC West Conference, held in April in Las Vegas. As a premier event focusing on security and public safety, ISC West provided an ideal platform for Astrotech to showcase its TRACER 1000 trace detector to industry professionals and decision-makers (https://ibn.fm/CHToD). The company’s participation underscores its dedication to staying at the forefront of technological advancements and addressing the evolving needs of the security market.

Thomas B. Pickens, III, Astrotech’s CEO, and Chief Technology Officer, said: “We are very excited about introducing our narcotics detection library that includes twelve illegal drugs including fentanyl, heroin, and cocaine.”  On the occasion, Pickens also said the company was extremely excited to share its user-friendly mass spectrometer the TRACER 1000 with leading industry experts and security industry professionals at the ISC West conference. “This allows us a platform to reach those in the industry across various markets, such as security, checkpoint, military, and law enforcement that strive for quality instrumentation, that requires a minimum amount of maintenance, and want accurate but rapid detection.”

For more information, visit the company’s website at www.AstrotechCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to ASTC are available in the company’s newsroom at https://ibn.fm/ASTC

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
Editor@MissionIR.com

MissionIR is powered by IBN